Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 5,159 | 4,752 | 3,539 | 2,026 | 0 |
| Cost of Goods | 2,060 | 1,948 | 2,341 | 1,278 | N/A |
| Gross Profit | 3,099 | 2,804 | 1,198 | 748 | N/A |
| Operating Expenses | 11,880 | 7,233 | 6,810 | 6,993 | 0 |
| Operating Income | -8,721 | -3,481 | -5,271 | -5,967 | N/A |
| Interest Expense | 694 | 679 | 673 | 638 | 0 |
| Other Income | 2,342 | -90 | -424 | -82 | 0 |
| Pre-tax Income | -7,073 | -4,250 | -6,368 | -6,687 | 0 |
| Net Income Continuous | -7,073 | -4,250 | -6,368 | -6,687 | N/A |
| Net Income | $-7,073 | $-4,250 | $-6,368 | $-6,687 | $N/A |
| EPS Basic Total Ops | -0.25 | -0.15 | -0.23 | -0.24 | N/A |
| EPS Basic Continuous Ops | 2.34 | -0.15 | -0.23 | -2.84 | N/A |
| EPS Diluted Total Ops | -0.25 | -0.15 | -0.23 | -0.24 | N/A |
| EPS Diluted Continuous Ops | 2.34 | -0.15 | -0.23 | -2.84 | N/A |
| EBITDA(a) | $-8,278 | $-3,106 | $-4,860 | $-5,534 | $N/A |